No insider purchase over the last 90 days. The latest, by 더블유자산운용, was filed 06 Jul 2026.
SK증권제13호스팩: what insiders have been doing
SK증권제13호스팩 belongs to the Banks sector. Filings by its managers are published through DART (FSS). The last twelve months, up to 1 November 2026, brought 3 filings signed by 2 insiders.
Every open-market trade in the period is a purchase: 2 purchases, from 1 insider, and not a single sale. No amount is published for 2 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 major shareholder among the declarants.
The latest purchase dates back some time: it was published 125 days ago, on 6 July 2026.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 3 filings here. Over the whole record (from 2024), the tally stands at 6 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: BAWAG Group AG and Linc AB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleFinancial data
as of FY 2025FY ended December 2025 · cache
- 141,455 sharesKRXDART:20260706000472Canonical exit: 4 Oct 2026 (T+90)
- 141,455 sharesKRXDART:20260706000402Canonical exit: 4 Oct 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 300,000 sharesKRXDART:20240729000232Canonical exit: 23 Oct 2024 (T+90)
- 400,000 sharesKRXDART:20240726000368Canonical exit: 23 Oct 2024 (T+90)
- 1,000,000 sharesKRXDART:20240725000133Canonical exit: 23 Oct 2024 (T+90)
- 300,000 sharesKRXDART:20240725000026Canonical exit: 23 Oct 2024 (T+90)
8 of 8 declarations
About SK증권제13호스팩
SK증권제13호스팩 is an investment company focused on financial operations, listed on the XKRX market. It operates within the finance and banking sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
